FORT LAUDERDALE, Fla., May 17, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve ...
Laura Bobolts, PharmD, BCOP, and James M. Cleary, MD, PhD, explore the evolution of treatment for patients with upper GI and esophageal cancer, including first- and second-line treatment strategies ...
Upper gastrointestinal (GI) cancers include cancer of the esophagus (the tube that carries food from the mouth to the stomach), the stomach, and the small intestine. These cancers can sometimes be ...
FORT LAUDERDALE, Fla., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and ...
Key opinion leaders navigate unmet needs across the treatment landscape of gastroesophageal cancer. Laura Bobolts, PharmD, BCOP: The unmet need for patients with esophageal and upper–GI ...